Allianz Asset Management GmbH - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 126 filers reported holding FATE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.88 and the average weighting 0.5%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$617,000
-71.4%
24,918
-55.3%
0.00%
-50.0%
Q1 2022$2,160,000
-32.5%
55,724
+2.3%
0.00%0.0%
Q4 2021$3,200,000
+71.3%
54,469
+72.8%
0.00%
+100.0%
Q3 2021$1,868,000
-29.2%
31,524
+3.7%
0.00%
-50.0%
Q2 2021$2,640,000
-28.3%
30,413
-31.9%
0.00%
-50.0%
Q1 2021$3,680,000
-11.3%
44,644
-2.1%
0.00%0.0%
Q4 2020$4,147,000
+489.9%
45,608
+44.0%
0.00%
+300.0%
Q1 2020$703,000
-19.5%
31,670
-29.0%
0.00%0.0%
Q4 2019$873,000
+28.0%
44,601
+1.5%
0.00%0.0%
Q3 2019$682,000
-69.1%
43,947
-59.5%
0.00%
-50.0%
Q2 2019$2,204,000
+14.5%
108,566
-0.9%
0.00%0.0%
Q1 2019$1,925,000
+38.5%
109,549
+1.1%
0.00%0.0%
Q4 2018$1,390,000
-21.1%
108,361
+0.2%
0.00%0.0%
Q3 2018$1,761,000
+5580.6%
108,132
+492.4%
0.00%
Q2 2016$31,000
-91.3%
18,252
-90.8%
0.00%
Q1 2016$355,000
-49.6%
197,329
-5.7%
0.00%
-100.0%
Q4 2015$705,000
-31.4%
209,307
+8.7%
0.00%0.0%
Q3 2015$1,027,000192,5960.00%
Other shareholders
FATE THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
ARCH Venture Management, LLC 716,392$11,126,00012.18%
Polaris Venture Management Co. V, L.L.C. 1,139,783$17,701,00010.06%
Grosvenor Holdings, L.L.C. 2,285,714$35,497,0006.41%
Redmile Group, LLC 11,216,809$174,197,0005.83%
Casdin Capital, LLC 2,550,000$39,601,500,0004.10%
DAFNA Capital Management LLC 470,000$7,299,0002.74%
Ghost Tree Capital, LLC 350,000$5,436,0001.38%
Artal Group S.A. 2,000,000$31,060,0001.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,952,897$30,328,0001.24%
Copernicus Capital Management, LLC 75,000$1,165,0001.08%
View complete list of FATE THERAPEUTICS INC shareholders